Nitrogen

Description

No description information is available for the drug.

Uses and Indications

This drug is indicated for use in patients as determined by healthcare professionals based on clinical judgment. Currently, the document does not provide specific indications or usage details for this drug.

There are no reported teratogenic or nonteratogenic effects associated with this drug as per the available information. Healthcare providers should consider this lack of data when prescribing and monitoring treatment.

Dosage and Administration

The active ingredient is nitrogen, comprising 99% of the formulation in a 100 L volume. This product is intended for respiratory administration via inhalation.

Healthcare professionals should ensure that the appropriate cylinder size is selected based on the clinical requirements. Available cylinder sizes include 6400 L, 3256 L, 6501 L, 8636 L, 180 L, 185 L, 190 L, 195 L, and 200 L.

Prior to administration, it is essential to verify the integrity of the cylinder and the delivery system. The inhalation method should be performed in a controlled environment, ensuring that the patient is positioned comfortably to facilitate effective inhalation.

Dosage should be determined based on the specific clinical scenario and patient needs, with careful monitoring of the patient's response to therapy. Adjustments to the dosage or frequency of administration may be necessary based on individual patient requirements and clinical judgment.

Contraindications

Use of this product is contraindicated in the following situations:

Handling should not occur until all safety precautions have been thoroughly read and understood. The product must be used and stored exclusively outdoors or in a well-ventilated area to mitigate risks associated with potential exposure. It is essential to utilize equipment that is rated for cylinder pressure to ensure safety during use. The valve must be closed after each use and when the cylinder is empty to prevent accidental release. Additionally, the product should be protected from sunlight when ambient temperatures exceed 52°C (125°F) to avoid degradation or hazardous conditions.

Warnings and Precautions

Inhalation of the substance necessitates immediate action. If inhaled, the individual should be promptly removed to an area with fresh air and kept comfortable for breathing. It is imperative to seek medical advice or attention without delay.

General precautions must be observed to ensure safe handling and usage. A backflow preventive device should be utilized in the piping to prevent contamination. The equipment employed must be rated for the cylinder pressure to avoid any risk of failure. After each use, and when the cylinder is empty, the valve should be securely closed. Additionally, the substance must be protected from sunlight, particularly when ambient temperatures exceed 52°C (125°F). Prior to use, it is essential to read and adhere to the Safety Data Sheet (SDS) to understand the risks and safety measures associated with the substance.

Currently, there are no specific laboratory tests recommended for monitoring the use of this substance. However, healthcare professionals should remain vigilant and prepared to provide emergency medical assistance if inhalation occurs.

Side Effects

Patients may experience a range of adverse reactions associated with nitrogen exposure. Serious side effects include hypoxia, asphyxiation, severe respiratory distress, loss of consciousness, and potentially fatal outcomes in cases of prolonged exposure to high concentrations. It is important to note that nitrogen acts as an asphyxiant, and exposure to elevated levels can lead to unconsciousness and death.

Common adverse reactions reported include dizziness, headache, and nausea. These symptoms are indicative of nitrogen inhalation and should be monitored closely in affected individuals.

Drug Interactions

There are currently no documented drug interactions associated with this medication. Additionally, there are no known interactions with laboratory tests. As such, no specific recommendations for dosage adjustments or monitoring are necessary at this time.

Packaging & NDC

The table below lists all NDC Code configurations of Nitrogen, the U.S. brand-name prescription product. Columns show Packaging, Formulation Type, and Active Ingredient Strength.

Pediatric Use

No pediatric use information is provided in the insert. Therefore, the safety and efficacy of this medication in pediatric patients have not been established. Healthcare professionals should exercise caution when considering this treatment for children, infants, or adolescents, as there are no available data to guide dosing or therapeutic outcomes in these populations.

Geriatric Use

There is no specific information available regarding the use of this medication in geriatric patients, including dosage adjustments, safety concerns, or special precautions. Healthcare providers should exercise caution when prescribing this medication to elderly patients, as individual responses may vary. Monitoring for potential adverse effects and therapeutic efficacy is recommended in this population.

Pregnancy

There is no information available regarding the use of this drug during pregnancy, including safety concerns, dosage modifications, or any special precautions that should be taken. Healthcare professionals are advised to consider the lack of data when prescribing this medication to pregnant patients and to weigh the potential risks and benefits. Women of childbearing potential should be counseled accordingly.

Lactation

There is no relevant information regarding nursing mothers or lactation considerations available in the provided text. Therefore, the effects of this medication on breastfed infants and its excretion in breast milk remain undetermined. Healthcare professionals should exercise caution and consider the potential risks and benefits when prescribing this medication to lactating mothers.

Renal Impairment

There is no information available regarding dosage adjustments, special monitoring, or safety considerations for patients with renal impairment. Healthcare professionals should exercise caution and consider the lack of specific guidance when prescribing to patients with reduced kidney function.

Hepatic Impairment

There is no available information regarding the use of this medication in patients with hepatic impairment. Consequently, there are no dosage adjustments, special monitoring requirements, or precautions specified for individuals with compromised liver function. Healthcare professionals should exercise caution and consider the overall clinical context when prescribing this medication to patients with liver problems, as the absence of specific guidance necessitates careful evaluation of potential risks and benefits.

Overdosage

There is currently no specific information available regarding overdosage for this medication. In the absence of documented overdosage data, healthcare professionals are advised to exercise caution and monitor patients closely for any unusual symptoms or adverse effects that may arise following administration.

In the event of suspected overdosage, it is recommended that healthcare providers initiate supportive care and symptomatic treatment as necessary. Continuous monitoring of vital signs and clinical status is essential to ensure patient safety.

Healthcare professionals should also consider consulting a poison control center or relevant toxicology resources for guidance on management strategies tailored to the specific circumstances of the overdosage event.

Nonclinical Toxicology

No teratogenic or non-teratogenic effects have been reported in the available nonclinical studies. Additionally, there is no information regarding animal pharmacology and toxicology. The absence of data limits the assessment of potential risks associated with the compound in these areas.

Postmarketing Experience

No postmarketing experience details are available in the provided text.

Patient Counseling

Healthcare providers should advise patients that the product contains gas under pressure and may explode if heated. It is crucial to inform patients that the product may displace oxygen, potentially leading to rapid suffocation. Patients should be instructed not to handle the product until they have read and understood all safety precautions.

Patients must be reminded to use and store the product only outdoors or in a well-ventilated area. It is important to emphasize the necessity of using a backflow preventive device in the piping and to utilize only equipment that is rated for cylinder pressure. Patients should be counseled to close the valve after each use and when the cylinder is empty.

Additionally, patients should be informed to protect the product from sunlight when the ambient temperature exceeds 52°C (125°F). They should be encouraged to read and follow the Safety Data Sheet (SDS) before use to ensure safe handling.

In the event of inhalation, patients should be instructed to remove themselves to fresh air and maintain a comfortable position for breathing. They should seek medical advice or attention if any adverse effects occur.

Storage and Handling

This product is supplied in a configuration that requires careful handling and storage. It must be used and stored exclusively outdoors or in a well-ventilated area to ensure safety and efficacy.

When ambient temperatures exceed 52°C (125°F), it is essential to protect the product from direct sunlight to prevent degradation. After each use and when the product is empty, the valve should be securely closed to maintain safety and prevent leaks.

Additionally, a backflow preventive device must be utilized in the piping to ensure proper operation and safety. It is crucial to use this product only with equipment that is rated for cylinder pressure to avoid any potential hazards.

Additional Clinical Information

No further data are available.

FDA Insert (PDF)

This document is the official FDA-approved prescribing information for Nitrogen as submitted by Volunteer Welding Supply Inc. It includes detailed information about indications, dosage, contraindications, warnings, and clinical pharmacology.

View full prescribing information (PDF)